Matches in Nanopublications for { ?s ?p "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP162678.RAjo75A7J2l5NkFqz05fS6J68cNDIFpgZ2FTMLxKkOoOE130_assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162678.RAjo75A7J2l5NkFqz05fS6J68cNDIFpgZ2FTMLxKkOoOE130_provenance.
- NP162854.RApchxw_UvfjyBm0T1djCIoytw5fq0flf6ybFbHDg3Fq0130_assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162854.RApchxw_UvfjyBm0T1djCIoytw5fq0flf6ybFbHDg3Fq0130_provenance.
- assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162251.RA00xzgfQW01KEVQPEl4KRCsj1-Blod0qDaRNlxuPffCM130_provenance.
- NP162261.RA3d3u-dBmy0O4KK-LHAN_BSRMSDukTFulnj80PVxhJsU130_assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162261.RA3d3u-dBmy0O4KK-LHAN_BSRMSDukTFulnj80PVxhJsU130_provenance.
- NP162506.RA_waRJ7Q8D20BpXVsbYyBTh96e_9bgS-HCWIbgytQgZg130_assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162506.RA_waRJ7Q8D20BpXVsbYyBTh96e_9bgS-HCWIbgytQgZg130_provenance.
- NP162792.RA0BeWS4cSz6IFeKveMMEKxx9MIr1Qq4P-lDjkq8O88kk130_assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162792.RA0BeWS4cSz6IFeKveMMEKxx9MIr1Qq4P-lDjkq8O88kk130_provenance.
- NP162457.RAELiaZ2rAYFCjipll0H7uz4LiTxRozVolF5hjuRfNhes130_assertion description "[of promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT, only the epigenetic silencing of TIMP3 and CDH1 predicted a better outcome in head and neck squamous cell carcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162457.RAELiaZ2rAYFCjipll0H7uz4LiTxRozVolF5hjuRfNhes130_provenance.